Historical record - last NADAC publication: 4/17/2024
Product Information
AMPICILLIN 2 GM VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $3.2338 per EA under NDC 65219002023. Its NADAC has been published 53 times since Apr 17, 2024.
Strength
2 g/1
Manufacturer
Fresenius Kabi USA, LLCNDC
65219002023
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
4/17/2024
Active Ingredients
AMPICILLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA062797On Market Since
10/31/2019
Pharmacological Classes
Price Statistics
The NADAC for AMPICILLIN 2 GM VIAL has been published 53 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2338 per EA |
|---|---|
| All-time high | $3.2338 (Apr 16, 2025) |
| All-time low | $3.2338 (Apr 17, 2024) |
| Median price | $3.2338 |
| Average price | $3.2338 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 53 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ampicillin sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMPICILLIN 2 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AMPICILLIN 2 GM VIAL, manufactured by Fresenius Kabi USA, LLC, is $3.2338 per EA (NDC 65219002023), effective Apr 16, 2025.
How has the price of AMPICILLIN 2 GM VIAL changed over time?
Over the history we have for it, the NADAC for AMPICILLIN 2 GM VIAL has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AMPICILLIN 2 GM VIAL?
Since Apr 17, 2024, the NADAC for AMPICILLIN 2 GM VIAL has ranged from a low of $3.2338 (Apr 17, 2024) to a high of $3.2338 (Apr 16, 2025), with a median of $3.2338 per EA.
Are there cheaper alternatives to AMPICILLIN 2 GM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMPICILLIN 2 GM VIAL, so no direct lower-cost alternative is listed.
Who manufactures AMPICILLIN 2 GM VIAL?
AMPICILLIN 2 GM VIAL (NDC 65219002023) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification